United Therapeutics | UTHR - Loan Capital



United Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.


Loan Capital Change Date
Amarin USD 0 0 Mar/2025
Ardelyx USD 229.21M 78.36M Jun/2025
Baxter International USD 9.41B 962M Mar/2025
Bayer EUR 31.71B 3.31B Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
BioMarin Pharmaceutical USD 596.16M 512K Jun/2025
Gilead Sciences USD 22.14B 6M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Insmed USD 560.95M 567.39M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
J&J USD 38.36B 7.7B Mar/2025
Moderna USD 32M 3M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
PTC Therapeutics USD 2.13B 1.85B Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Jun/2025
Sarepta Therapeutics USD 1.14B 1.17M Jun/2025
Teva Pharmaceutical Industries USD 16.76B 533M Jun/2025
United Therapeutics USD 0 0 Mar/2025
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024